Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Key Growth Enablers
2.5. Key Challenges

3. Key Analytics
3.1. Porter’S Five Forces Analysis
3.1.1. Threat Of New Entry
3.1.2. Threat Of Substitution
3.1.3. Buyer’S Power
3.1.4. Supplier’S Power
3.1.5. Competitive Rivalry
3.2. Impact Of Covid-19 On Irritable Bowel Syndrome Treatment Market
3.3. Regulatory Framework
3.4. Opportunity Matrix
3.5. Vendor Landscape
3.6. Key Investment Insights

4. Market By Type
4.1. Ibs With Diarrhea
4.2. Ibs With Constipation
4.3. Mixed Ibs

5. Market By Product
5.1. Rifaximin
5.2. Eluxadoline
5.3. Linaclotide
5.4. Lubiprostone
5.5. Other Products

6. Market By Distribution Channel
6.1. Drug Stores And Retail Pharmacies
6.2. Hospitals’ Pharmacies
6.3. Online Pharmacies

7. Market By Mechanism Of Action
7.1. 5Ht3 Antagonist
7.2. Guanylate Cyclase Receptor-C Agonist
7.3. Chloride Channel Activator
7.4. Other Mechanism Of Actions

8. Market By Dosage
8.1. Solid
8.2. Liquid

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Merger & Acquisitions
9.1.2. Product Launch & Developments
9.1.3. Partnership, Contract/Agreement & Collaboration
9.1.4. Business Expansion/ Approval/ Announcement
9.2. Company Profile
9.2.1. Abbott Laboratories
9.2.2. Allergan Plc
9.2.3. Astrazeneca Plc
9.2.4. Glaxosmithkline Plc
9.2.5. Novartis Ag



List of Figures


Figure 1: Porter’S Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: India Irritable Bowel Syndrome Treatment Market, By Type, In 2020
Figure 6: India Irritable Bowel Syndrome Treatment Market, By Ibs With Diarrhea, 2021-2026 (In $ Million)
Figure 7: India Irritable Bowel Syndrome Treatment Market, By Ibs With Constipation, 2021-2026 (In $ Million)
Figure 8: India Irritable Bowel Syndrome Treatment Market, By Mixed Ibs, 2021-2026 (In $ Million)
Figure 9: India Irritable Bowel Syndrome Treatment Market, By Product, In 2020
Figure 10: India Irritable Bowel Syndrome Treatment Market, By Rifaximin, 2021-2026 (In $ Million)
Figure 11: India Irritable Bowel Syndrome Treatment Market, By Eluxadoline, 2021-2026 (In $ Million)
Figure 12: India Irritable Bowel Syndrome Treatment Market, By Linaclotide, 2021-2026 (In $ Million)
Figure 13: India Irritable Bowel Syndrome Treatment Market, By Lubiprostone, 2021-2026 (In $ Million)
Figure 14: India Irritable Bowel Syndrome Treatment Market, By Other Products, 2021-2026 (In $ Million)
Figure 15: India Irritable Bowel Syndrome Treatment Market, By Distribution Channel, In 2020
Figure 16: India Irritable Bowel Syndrome Treatment Market, By Drug Stores And Retail Pharmacies, 2021-2026 (In $ Million)
Figure 17: India Irritable Bowel Syndrome Treatment Market, By Hospitals’ Pharmacies, 2021-2026 (In $ Million)
Figure 18: India Irritable Bowel Syndrome Treatment Market, By Online Pharmacies, 2021-2026 (In $ Million)
Figure 19: India Irritable Bowel Syndrome Treatment Market, By Mechanism Of Action, In 2020
Figure 20: India Irritable Bowel Syndrome Treatment Market, By 5Ht3 Antagonist, 2021-2026 (In $ Million)
Figure 21: India Irritable Bowel Syndrome Treatment Market, By Guanylate Cyclase Receptor-C Agonist, 2021-2026 (In $ Million)
Figure 22: India Irritable Bowel Syndrome Treatment Market, By Chloride Channel Activator, 2021-2026 (In $ Million)
Figure 23: India Irritable Bowel Syndrome Treatment Market, By Other Mechanism Of Actions, 2021-2026 (In $ Million)
Figure 24: India Irritable Bowel Syndrome Treatment Market, By Dosage, In 2020
Figure 25: India Irritable Bowel Syndrome Treatment Market, By Solid, 2021-2026 (In $ Million)
Figure 26: India Irritable Bowel Syndrome Treatment Market, By Liquid, 2021-2026 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT – IRRITABLE BOWEL SYNDROME TREATMENT
TABLE 2: INDIA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: INDIA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 4: INDIA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: INDIA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY PRODUCT, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 6: INDIA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: INDIA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 8: INDIA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY MECHANISM OF ACTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: INDIA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY MECHANISM OF ACTION, FORECAST YEARS, 2021-2026 (IN $ MILLION)
TABLE 10: INDIA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY DOSAGE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: INDIA IRRITABLE BOWEL SYNDROME TREATMENT MARKET, BY DOSAGE, FORECAST YEARS, 2021-2026 (IN $ MILLION)